JiangXi Tianxin Pharmaceutical Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

JiangXi Tianxin Pharmaceutical Co., Ltd.

Why is JiangXi Tianxin Pharmaceutical Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -3.41% and Operating profit at -7.92% over the last 5 years

With a fall in Net Sales of -12.4%, the company declared Very Negative results in Mar 25

INTEREST(HY) At CNY 3.95 MM has Grown at 88.13%
OPERATING CASH FLOW(Y) Lowest at CNY 587 MM
DEBT-EQUITY RATIO (HY) Highest at -29.03 %

Underperformed the market in the last 1 year

The stock has generated a return of 1.20% in the last 1 year, much lower than market (China Shanghai Composite) returns of 14.77%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is JiangXi Tianxin Pharmaceutical Co., Ltd. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

JiangXi Tianxin Pharmaceutical Co., Ltd.

-100.0%

0.27

21.06%

China Shanghai Composite

15.19%

1.01

14.58%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-3.41%

EBIT Growth (5y)

-7.92%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.29

Sales to Capital Employed (avg)

0.45

Tax Ratio

15.62%

Dividend Payout Ratio

45.64%

Pledged Shares

Institutional Holding

ROCE (avg)

28.29%

ROE (avg)

18.62%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.84

EV to EBIT

4.18

EV to EBITDA

3.34

EV to Capital Employed

0.79

EV to Sales

1.26

PEG Ratio

0.17

Dividend Yield

ROCE (Latest)

18.92%

ROE (Latest)

14.10%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bearish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

19What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -29.49% (YoY

NET SALES(Q)

Highest at CNY 614.06 MM

OPERATING PROFIT(Q)

Highest at CNY 238 MM

OPERATING PROFIT MARGIN(Q)

Highest at 38.76 %

PRE-TAX PROFIT(Q)

Highest at CNY 262.12 MM

NET PROFIT(Q)

Highest at CNY 220.42 MM

EPS(Q)

Highest at CNY 0.5

-14What is not working for the Company

INTEREST(HY)

At CNY 3.95 MM has Grown at 88.13%

OPERATING CASH FLOW(Y)

Lowest at CNY 587 MM

DEBT-EQUITY RATIO (HY)

Highest at -29.03 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.54%

Here's what is working for JiangXi Tianxin Pharmaceutical Co., Ltd.

Net Sales

Highest at CNY 614.06 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Net Sales

At CNY 614.06 MM has Grown at 25.48%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Operating Profit

Highest at CNY 238 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (CNY MM)

Operating Profit Margin

Highest at 38.76 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit

Highest at CNY 262.12 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 220.42 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.5

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Raw Material Cost

Fallen by -29.49% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for JiangXi Tianxin Pharmaceutical Co., Ltd.

Interest

At CNY 3.95 MM has Grown at 88.13%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Cash Flow

Lowest at CNY 587 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Debt-Equity Ratio

Highest at -29.03 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio

Lowest at 2.54%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio